Literature DB >> 11034398

Identification of a novel cytokine response element in the human IFN regulatory factor-1 gene promoter.

D Imanishi1, K Yamamoto, H Tsushima, Y Miyazaki, K Kuriyama, M Tomonaga, T Matsuyama.   

Abstract

The present study investigates the regulatory mechanisms involved in the cooperation between IFN-gamma and TNF-alpha to promote transcription from IFN regulatory factor-1 (IRF-1). A transient transfection analysis revealed that the region between -218 and -144, where +1 is the transcription start site, as well as previously reported downstream elements, ppkappaB and IFN-gamma activation site/kappaB, were required for the optimal response to the two cytokines. A subsequent DNase I footprint analysis showed that the region between -171 and -144 was inducibly protected with stimulation by TNF-alpha, and this protection was significantly enhanced with the combination of IFN-gamma and TNF-alpha. In an EMSA with the protected region as a probe, a TNF-alpha-inducible complex (C1) and an IFN-gamma-inducible complex (C2), but no synergy-specific DNA-protein complexes, were recognized. The C1 complex consisted of a pre-existing factor (p65/p50), whereas the C2 complex consisted of a newly synthesized IRF-1-related factor. A methylation interference assay revealed the critical G residues (from -167 to -151) for the DNA-protein complex formation specific to the cytokine response, and within this region the novel kappaB sequence, the promoter distal kappaB (pdkappaB) element (5'-GGGGAAG TAC-3'), was identified. Because the base substitutions over the pdkappaB region (from -171 to -144) affected not only the TNF-alpha-response but also that of IFN-gamma, this region might contribute to the cooperative action of the NF-kappaB subunits with the IRF-1-related factor. Finally, we demonstrated that none of the cis-acting elements, ppkappaB, pdkappaB, or IFN-gamma activation site/kappaB, is dispensable for the optimal synergism in response to IFN-gamma and TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11034398     DOI: 10.4049/jimmunol.165.7.3907

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein.

Authors:  Jirí Nehyba; Radmila Hrdlicková; Joan Burnside; Henry R Bose
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Antiviral and immunoregulatory activities of IFN-gamma depend on constitutively expressed IL-1alpha.

Authors:  Vladimir Hurgin; Daniela Novick; Ariel Werman; Charles A Dinarello; Menachem Rubinstein
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-08       Impact factor: 11.205

3.  Quantitation of the dynamic profiles of the innate immune response using multiplex selected reaction monitoring-mass spectrometry.

Authors:  Yingxin Zhao; Bing Tian; Chukwudi B Edeh; Allan R Brasier
Journal:  Mol Cell Proteomics       Date:  2013-02-15       Impact factor: 5.911

4.  Ferritin H induction by histone deacetylase inhibitors.

Authors:  Wei Wang; Xiumin Di; Suzy V Torti; Frank M Torti
Journal:  Biochem Pharmacol       Date:  2010-04-10       Impact factor: 5.858

5.  Growth arrest of epithelial cells during measles virus infection is caused by upregulation of interferon regulatory factor 1.

Authors:  Shin-ichi Yokota; Tamaki Okabayashi; Noriko Yokosawa; Nobuhiro Fujii
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

6.  Suppression of growth by all-trans retinoic acid requires prolonged induction of interferon regulatory factor 1 in cervical squamous carcinoma (SiHa) cells.

Authors:  Istvan Arany; William E Whitehead; Kenneth J Grattendick; Istvan A Ember; Stephen K Tyring
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

7.  Interferon regulatory factor-1 polymorphisms are associated with the control of Plasmodium falciparum infection.

Authors:  V D Mangano; G Luoni; K A Rockett; B S Sirima; A Konaté; J Forton; T G Clark; G Bancone; E Sadighi Akha; E S Akha; D P Kwiatkowski; D Modiano
Journal:  Genes Immun       Date:  2008-01-17       Impact factor: 2.676

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.